A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Pneumonia: An Interim Analysis

Extensively drug-resistant A. baumannii (XDRAB) pneumonia has a high mortality rate in hospitalized patients. One of the recommended treatments is colistin combined with sulbactam; however, the optimal dosage of sulbactam is unclear. In an open-label, superiority, randomized controlled trial, patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ungthammakhun, Chutchawan, Vasikasin, Vasin, Changpradub, Dhitiwat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405071/
https://www.ncbi.nlm.nih.gov/pubmed/36009980
http://dx.doi.org/10.3390/antibiotics11081112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405071/
https://www.ncbi.nlm.nih.gov/pubmed/36009980
http://dx.doi.org/10.3390/antibiotics11081112

Ejemplares similares